rs3905011

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.513-1308A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.579 in 152,100 control chromosomes in the GnomAD database, including 25,776 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.58 ( 25776 hom., cov: 33)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.95

Publications

5 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.679 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.513-1308A>G intron_variant Intron 3 of 47 ENST00000367573.7 NP_001192222.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.513-1308A>G intron_variant Intron 3 of 47 1 NM_001205293.3 ENSP00000356545.2
CACNA1EENST00000360108.7 linkc.513-1308A>G intron_variant Intron 3 of 46 5 ENSP00000353222.3
CACNA1EENST00000367570.6 linkc.513-1308A>G intron_variant Intron 3 of 46 1 ENSP00000356542.1
CACNA1EENST00000621791.4 linkc.513-1308A>G intron_variant Intron 3 of 45 1 ENSP00000481619.1
CACNA1EENST00000524607.6 linkc.948-1308A>G intron_variant Intron 5 of 11 5 ENSP00000432038.2

Frequencies

GnomAD3 genomes
AF:
0.579
AC:
87939
AN:
151980
Hom.:
25744
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.531
Gnomad AMI
AF:
0.728
Gnomad AMR
AF:
0.558
Gnomad ASJ
AF:
0.639
Gnomad EAS
AF:
0.697
Gnomad SAS
AF:
0.594
Gnomad FIN
AF:
0.583
Gnomad MID
AF:
0.579
Gnomad NFE
AF:
0.597
Gnomad OTH
AF:
0.548
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.579
AC:
88023
AN:
152100
Hom.:
25776
Cov.:
33
AF XY:
0.584
AC XY:
43409
AN XY:
74370
show subpopulations
African (AFR)
AF:
0.531
AC:
22026
AN:
41484
American (AMR)
AF:
0.557
AC:
8518
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.639
AC:
2217
AN:
3468
East Asian (EAS)
AF:
0.698
AC:
3610
AN:
5172
South Asian (SAS)
AF:
0.596
AC:
2877
AN:
4826
European-Finnish (FIN)
AF:
0.583
AC:
6164
AN:
10564
Middle Eastern (MID)
AF:
0.568
AC:
167
AN:
294
European-Non Finnish (NFE)
AF:
0.597
AC:
40617
AN:
67984
Other (OTH)
AF:
0.553
AC:
1163
AN:
2104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1923
3846
5768
7691
9614
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
754
1508
2262
3016
3770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.583
Hom.:
4732
Bravo
AF:
0.573
Asia WGS
AF:
0.606
AC:
2107
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
0.0060
DANN
Benign
0.22
PhyloP100
-1.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3905011; hg19: chr1-181545594; API